[Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D001379:Azathioprine; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate
Le lupus érythémateux disséminé. De l'étiopathogénie au traitement dit "immunosuppressif".